483
GLPGCP Development (Asia) Pte. Ltd.FDA 483 - GLPGCP Development (Asia) Pte. Ltd. - April 19, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Humanoptics Ag., a manufacturer in Sankt Augustin, Germany, identified two significant issues. The firm was cited for inadequate validation of processes where results cannot be fully verified by subsequent inspection and test. Additionally, procedures for corrective and preventive action were found to be inadequately established.
Open in Dashboard
ID · 4fd7e91c-468e-4aed-8198-505eaef4128a